Korea vs Netherlands: Proportion of isolates with decreased susceptibility or resistance
Korea
0
in 2018
Netherlands
0
in 2018
Korea rank
25th
Netherlands rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- Korea
- Netherlands
How they compare
Korea currently reports 0 against 0 in Netherlands, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2009 it was Korea ahead.
Korea ranks 25th and Netherlands ranks 25th of 51 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.27 | 0 | 29.27 | Korea |
| 2010s | 15.66 | 0.6823 | 14.98 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Korea or Netherlands?
- Korea, at 0 against 0 in Netherlands as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Korea and Netherlands?
- 0, with Korea ahead.
- How many years of comparable data are there for Korea and Netherlands?
- 9 years are reported by both, from 2009 to 2018.
- How do Korea and Netherlands rank globally for proportion of isolates with decreased susceptibility or resistance?
- Korea ranks 25th and Netherlands ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.